Who
Joan E. Herman
Director
Company insider
Files Form 4 as: Director, Encompass Health; Director, Ionis Pharmaceuticals; Director, Convergys; Director, Mrv Communications; President & CEO Cons and EVP, Elevance Health.
In numbers
- Trades disclosed
- 233
- Buys
- 1
- Sells
- 12
- Bought
- $35K
- Sold
- $37.6M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 26 Jan 2006
- Last trade
- 15 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 19 Oct 2026 | EHC Encompass HealthProviders & Facilities | SEC FORM 4 Code A | —81 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | IONS Ionis PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —5,220 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,220 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,220 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | IONS Ionis PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —5,220 at $0.00 | filing |
| 15 Jul 2026filed 16 Jul 2026 | EHC Encompass HealthProviders & Facilities | SEC FORM 4 Code A | —85 at $0.00 | filing |
| 15 Jul 2026filed 16 Jul 2026 | EHC Encompass HealthProviders & Facilities | SEC FORM 4 Code A | —85 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,369 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,301 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,369 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,301 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | EHC Encompass HealthProviders & Facilities | SEC FORM 4 Code A | —1,634 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | EHC Encompass HealthProviders & Facilities | SEC FORM 4 Code A | —1,634 at $0.00 | filing |
| 15 Apr 2026filed 16 Apr 2026 | EHC Encompass HealthProviders & Facilities | SEC FORM 4 Code A | —85 at $0.00 | filing |
| 15 Apr 2026filed 16 Apr 2026 | EHC Encompass HealthProviders & Facilities | SEC FORM 4 Code A | —85 at $0.00 | filing |
| 15 Jan 2026filed 16 Jan 2026 | EHC Encompass HealthProviders & Facilities | SEC FORM 4 Code A | —87 at $0.00 | filing |
| 15 Jan 2026filed 16 Jan 2026 | EHC Encompass HealthProviders & Facilities | SEC FORM 4 Code A | —87 at $0.00 | filing |
| 19 Nov 2025filed 20 Nov 2025 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,000 at $0.00 | filing |
| 19 Nov 2025filed 20 Nov 2025 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —32,000 at $0.00 | filing |
| 19 Nov 2025filed 20 Nov 2025 | IONS Ionis PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $481K12,000 at $40.05 | filing |
News
Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells 1,357 Shares of StockIONS · dailypolitical.com · 20 Oct 2026Ionis Pharmaceuticals, Inc.: TRYNGOLZA (olezarsen) recommended for approval in the EU by CHMP for severe hypertriglyceridemia (sHTG)IONS · finanznachrichten.de · 16 Oct 2026Ionis Pharmaceuticals (NASDAQ:IONS) & Upstream Bio (NASDAQ:UPB) Head to Head ReviewIONS · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Joan E. Herman; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.